Wird geladen...
Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
Cancer cells release DNA fragments into plasma as circulating free DNA (cfDNA). However, quantitative measurement of tumor‐derived DNA in cfDNA remains challenge. The purpose of this study was to quantitatively assess tumor‐derived DNA in lung cancer patients. By optimizing competitive allele‐specif...
Gespeichert in:
| Veröffentlicht in: | Cancer Med |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5430107/ https://ncbi.nlm.nih.gov/pubmed/28382702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.980 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|